Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Matthias Augustin, Audrey Nosbaum, Thomas Werfel, Susanne Grond, Catherine Reed, Anastasia Lampropoulou, Nicole Tietz, Alan D. Irvine & Elisabeth Riedl. (2023) Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey. Journal of Dermatological Treatment 34:1.
Read now
Read now
Articles from other publishers (7)
Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney & William Romero. (2024) Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations. Dermatology and Therapy.
Crossref
Crossref
Gabriel Mercadal-Orfila, Carlos Seguí-Solanes, Nuria Rudi-Sola, Maria Eugenia Escriva-Sancho & Rosa Taberner-Ferrer. (2024) Medidas de resultados comunicados por el paciente para evaluar la dermatitis atópica. Farmacia Hospitalaria.
Crossref
Crossref
Eric Simpson, Peter Lio, Evangeline Pierce, Angel Cronin, Robert R. McLean, Thomas Eckmann, Amber Reck Atwater, Zach Dawson & Jonathan I. Silverberg. (2024) Impact of atopic dermatitis lesion locations and extent on patient burden: A real‐world study. JEADV Clinical Practice.
Crossref
Crossref
Judith Nicogossian, Stéphane Héas, Claire Thénié, Margaux Noel, Laurent Misery, Sebastien Barbarot & Fabienne Martin Juchat. (2024) Questions a patient with moderate to severe atopic dermatitis would like to be asked: Data from a qualitative study conducted by anthropologists. JEADV Clinical Practice.
Crossref
Crossref
Kim S Thomas, Laura Howells, Yael A Leshem, Eric L Simpson, Christian Apfelbacher, Phyllis I Spuls, Louise A A Gerbens, Michael E Jacobson, Norito Katoh, Hywel C Williams & Beth L Stuart. (2024) How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide. British Journal of Dermatology 190:4, pages 527-535.
Crossref
Crossref
Nicholas Shortt, Alexander Martin, Kyley Kerse, Gabrielle Shortt, Iva Vakalalabure, Luke Barker, Joseph Singer, Bianca Black, Angela Liu, Allie Eathorne, Mark Weatherall, Marius Rademaker, Mike Armour, Richard Beasley & Alex Semprini. (2022) Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial. eClinicalMedicine 51, pages 101561.
Crossref
Crossref
Takeshi Nakahara, Shunya Takemoto, Hiroyuki Houzawa & Masahiko Nakayama. (2022) Desire for Alternative Treatment Options in Patients with Atopic Dermatitis in Japan: Results of a Web-Based Cross-Sectional Study (AD-JOIN Study). Dermatology and Therapy 12:6, pages 1383-1396.
Crossref
Crossref